ASPET

Keiichiro Nakamura, a PhD student at Kitasato University, is the Drug Metabolism and Disposition Highlighted Trainee Author for June 2026. His research focuses on developing human-relevant experimental models to better understand how drugs are absorbed in the intestine. The research provides a new way to recreate human intestinal function in the laboratory, allowing scientists to study medicines under conditions that more closely resemble the human body.

“I hope that my research will help make human-relevant intestinal models more accessible to the broader pharmacology community,” he shared.

Read the article: https://doi.org/10.1016/j.dmd.2026.100306

Interested in learning how your organization can best advocate for science policy with elected officials, educational or industry decision-makers, or the general public?

ASPET’s Government Affairs and Science Policy (GASP) staff will visit you and your staff, or meet with you virtually, and provide on-hands guidance on how your voice can be heard!

Learn more and take advantage of this opportunity: https://ow.ly/LKLU50ZfWIR

DMD's Editor's Choice shows a necessity of reducing intestinal CYP3A4 by 50-90% for physiologically based pharmacokinetic modeling of oral CYP3A substrate exposure in cancer patients, implacable to dosing and drug-drug interaction prediction in oncology. Learn more: https://ow.ly/2Pn550Zg0tr

🚨 There’s one week left to submit your application for the ASPET Washington Fellows Program! If you are a graduate student, postdoc, or early career investigator, and are interested in science policy and advocacy or a potential career in policy, then this program is for you.

📅 Applications Due: Tuesday, June 30
🔗 Apply today: https://www.aspet.org/aspet/advocacy/aspet-washington-fellows-program

Thomas Burris, PhD, and winner of the 2026 Goodman and Gilman Award, presents “Drugging Time: Nuclear Receptors and the Pharmacological Control of Circadian Physiology.” Join us for this special presentation, open to both ASPET members and non-members: https://ow.ly/NYrF50Z4Pql

Make sure to submit your research to our upcoming collection in Molecular Pharmacology! Submissions due August 31. Learn more: https://ow.ly/JsPk50ZcOMK

Our most recent Featured Article in JPET is free-to-read for a limited time! Check out "Piperine-loaded solid dispersions mitigate amyloid-β-mediated oxidative stress and mitochondrial dysfunction in SH-SY5Y cells: A possible therapeutic strategy for Alzheimer's disease" and share it with your colleagues: https://ow.ly/yXFR50ZcOrY

Erica Levitt, PhD, PharmD, and winner of the 2026 John J. Abel Award, presents “Understanding Opioid Overdose: One Breath at a Time.” This special presentation is open to both ASPET members and non-members. Learn more and register: https://ow.ly/iffj50Z4PfF

Ben Clements, PhD, a Postdoctoral Research Fellow at the University of Michigan, is the Journal of Pharmacology and Experimental Therapeutics Highlighted Trainee Author for June 2026. His research focuses on the characterization of novel pain therapeutics, ranging from NMDA receptor antagonists to opioid receptor allosteric modulators.  
 
“My work aims to create new ways to provide pain relief to patients, with the goal of making new medications for transition from the bench to patients,” he shared.
 
➡️ Read the article via the link in out bio.

Ben Clements, PhD, a Postdoctoral Research Fellow at the University of Michigan, is the Journal of Pharmacology and Experimental Therapeutics Highlighted Trainee Author for June 2026. His research focuses on the characterization of novel pain therapeutics, ranging from NMDA receptor antagonists to opioid receptor allosteric modulators.

“My work aims to create new ways to provide pain relief to patients, with the goal of making new medications for transition from the bench to patients,” he shared.

🔗 Read the article: https://doi.org/10.1016/j.jpet.2026.104891